Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost Analysis
Collections
Language
eng
License start date
2018-04
Citation
Clinical Pharmacology & Therapeutics, 2018, 103 (4), pp. 582 - 590
Publisher
Wiley